Clinical Trial Update: Pharmacogenomics Effects on High-Dose Methotrexate Clearance in Patients With Diffuse Large B-Cell Lymphoma

View source ↗

Summary

This trial update reports on pharmacogenomics effects on the clearance of high-dose methotrexate in patients with diffuse large B-cell lymphoma, including centr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Central Nervous System Lymphoma
• Diffuse Large B-cell Lymphoma

Drugs mentioned

• METHOTREXATE (METHOTREXATE)

Snippet

Sponsor: Ohio State University Comprehensive Cancer Center | Conditions: Central Nervous System Lymphoma, Diffuse Large B-Cell Lymphoma | Status: COMPLETED